Jump to Main Content
- Li, Yong; Yang, Panchun; Lei, Ning; Ma, Yihan; Ji, Yaoting; Zhu, Chunnan; Wu, Yunhua
- Analytical chemistry 2018 v.90 no.19 pp. 11495-11502
- DNA; antibodies; bioluminescence; biomarkers; blood sampling; detection limit; diagnostic techniques; energy transfer; green fluorescent protein; humans; luciferase; mobile telephones; oligonucleotides; point-of-care systems; polymers; prostate-specific antigen; spectrophotometers
- ... By virtue of its self-illuminating mechanism, the bioluminescence resonance energy transfer (BRET) technique has recently emerged as a promising platform for point-of-care (POC) diagnostics. However, due to the difficulty of incorporating generic affinity elements, such as aptamers and antibodies, current BRET-based methods are still not applicable to most clinically important biomarkers. Furtherm ...
- Yang, Ke; Li, Jun; Zhao, Jiuzhou; Ren, Pengfei; Wang, Zhizhong; Wei, Bing; Dong, Bing; Sun, Rui; Wang, Xiaoyan; Groen, Harry J. M.; Ma, Jie; Guo, Yongjun
- Analytical chemistry 2018 v.90 no.19 pp. 11203-11209
- DNA; alleles; detection limit; disease course; droplets; drugs; enzyme inhibitors; epidermal growth factor receptors; high-throughput nucleotide sequencing; lung neoplasms; monitoring; mutation; patients; polymerase chain reaction; therapeutics
- ... A T790M secondary mutation in epidermal-growth-factor receptor (EGFR) is the most well-established EGFR-tyrosine-kinase-inhibitor (TKI) resistance marker in non-small-cell lung cancer (NSCLC). The current methods to rapidly and accurately detect T790M in clinical practice are not satisfactory because of several obstacles, including the unavailability of tumor-tissue rebiopsies and the low DNA copy ...